Clinical Trials Directory

Trials / Completed

CompletedNCT03302702

Duration of Exercise Program in Interstitial Lung Diseases.

A Comparison Trial of Eight Weeks Versus Twelve Weeks of Exercise Program in Interstitial Lung Diseases.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Izmir Katip Celebi University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

We aimed to compare the functional results of the 8th week with the results of the 12th week of the exercise programs applied to the patients with ILD.

Detailed description

Exercise programs (EP) have been shown to be the effective approach for functional outcomes in interstitial lung diseases (ILD). In many studies, the duration of exercise programs varies between 8-12 weeks. However, the optimal duration of exercise program is still unknown. We aimed to compare the results of the 8th week with the results of the 12th week of the PR programs applied to the patients with ILD. A total of 14 patients with ILD referred to our PR unit \[11 idiopathic pulmonary fibrosis, 2 sarcoidosis (stage 3 and 4) and 1 nonspecific interstitial pneumonia\] were included in the study. Pulmonary function test, arterial blood gas analysis, 6- minute walk test, mMRC dyspnea scale, quality of life questionnaires and hospital anxiety depression scale were performed before, at the 8th and 12th weeks after the exercise program applied to the patients twice a week.

Conditions

Interventions

TypeNameDescription
OTHERExercise programExercise program including breathing control, pursed-lip breathing, diaphragmatic and thoracic breathing, aerobic and strengthening training

Timeline

Start date
2014-01-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2017-10-05
Last updated
2017-10-05

Source: ClinicalTrials.gov record NCT03302702. Inclusion in this directory is not an endorsement.